Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

33.62 -0.25 (-0.75%)

Streaming Delayed Price Updated: 2:33 PM EDT, Mar 9, 2026 Add to My Watchlist

Price and Volume

Volume	585,586
Open	33.57
Bid (Size)	33.59 (400)
Ask (Size)	33.64 (200)
Prev. Close	33.87
Today's Range	33.10 - 33.84
52wk Range	28.66 - 117.33
Shares Outstanding	115,926,629
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026

March 08, 2026

NEW YORK, NY - March 8, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:...

Via TheNewswire.com

Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026

March 08, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Performance

YTD	-12.0%	-12.0%
1 Month	-17.7%	-17.7%
3 Month	-59.5%	-59.5%
6 Month	-52.8%	-52.8%
1 Year	-40.4%	-40.4%

More News

CORT ALERT: Deadline in Securities Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) is April 21, 2026 - Contact Kaplan Fox

March 07, 2026

Via TheNewswire.com

CORT ALERT: Deadline in Securities Class Action Lawsuit against Corcept Therapeutics, Inc. (NASDAQ: CORT) is April 21, 2026 - Contact Kaplan Fox

March 07, 2026

Via NewMediaWire

CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026

March 06, 2026

Via TheNewswire.com

CORCEPT THERAPEUTICS CLASS ACTION DEADLINE: Kaplan Fox Encourages Corcept Therapeutics, Inc. (NASDAQ: CORT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on April 21, 2026

March 06, 2026

Via NewMediaWire

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm

March 06, 2026

From Schall Law

Via GlobeNewswire

CORT DEADLINE: Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Deadline on April 21, 2026

March 06, 2026

Via NewMediaWire

CORT DEADLINE: Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Deadline on April 21, 2026

March 06, 2026

Via TheNewswire.com

Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your

March 05, 2026

From Grabar Law Office

Via GlobeNewswire

CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Corcept Therapeutics Incorporated Investors of Upcoming Deadline

March 05, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

March 04, 2026

From SkyMedia, LLC

Via GlobeNewswire

Law Offices of Frank R. Cruz Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action

March 04, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

March 03, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Integer Holdings Corp. (NYSE: ITGR); Kyndryl Holdings (NYSE: KD); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf

March 03, 2026

From Grabar Law Office

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT

March 03, 2026

From Pomerantz LLP

Via GlobeNewswire

Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

March 03, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm

March 03, 2026

From Schall Law

Via GlobeNewswire

Investors of Corcept Therapeutics, Inc. (CORT) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 21, 2026

March 03, 2026

Via NewMediaWire

Investors of Corcept Therapeutics, Inc. (CORT) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 21, 2026

March 03, 2026

Via TheNewswire.com

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT)

March 03, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Deadline to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (CORT) is April 21, 2026 - Contact Kaplan Fox

March 02, 2026

Via NewMediaWire

Deadline to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (CORT) is April 21, 2026 - Contact Kaplan Fox

March 02, 2026

Via TheNewswire.com

Deadline Approaching: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

March 02, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Five9, Inc. (NASDAQ: FIVN); Integer Holdings Corp. (NYSE: ITGR); and Kyndryl Holdings (NYSE: KD): Grabar Law Office Investigates Claims on Your Behalf

March 02, 2026

From Grabar Law Office

Via GlobeNewswire

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?

Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.

What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?

Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?

The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market

What is the current price of Corcept Therapeutics Incorporated - Common Stock?

The current price of Corcept Therapeutics Incorporated - Common Stock is 33.62

When was Corcept Therapeutics Incorporated - Common Stock last traded?

The last trade of Corcept Therapeutics Incorporated - Common Stock was at 03/09/26 02:33 PM ET

What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?

The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 3.90B

How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?

Corcept Therapeutics Incorporated - Common Stock has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.